This week, Artoss will launch NanoBone® QD bone graft, comprising NanoBone SBX putty in an application designed for quick delivery. Artoss is the exclusive North American distributor for NanoBone in orthopedic applications.
NanoBone synthetic grafts have been used in the U.S. and EU for over ten years in nearly 400,000 cases across all indications.
Last month, Artoss entered into a Defense Acquisition Purchasing Agreement with Owens & Minor supporting U.S. Department of Defense purchase of all NanoBone bone graft products.
This week, Artoss will launch NanoBone® QD bone graft, comprising NanoBone SBX putty in an application designed for quick delivery. Artoss is the exclusive North American distributor for NanoBone in orthopedic applications.
NanoBone synthetic grafts have been used in the U.S. and EU for over ten years in nearly 400,000 cases across all...
Image from artossinc.com
This week, Artoss will launch NanoBone® QD bone graft, comprising NanoBone SBX putty in an application designed for quick delivery. Artoss is the exclusive North American distributor for NanoBone in orthopedic applications.
NanoBone synthetic grafts have been used in the U.S. and EU for over ten years in nearly 400,000 cases across all indications.
Last month, Artoss entered into a Defense Acquisition Purchasing Agreement with Owens & Minor supporting U.S. Department of Defense purchase of all NanoBone bone graft products.
Copy to clipboard 
